Hepatic adverse events during treatment with immune checkpoint inhibitors (ICI) in cancer patients: A territory-wide patient cohort study.

Authors

Stephen Chan

Stephen Lam Chan

Department of Clinical Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China

Stephen Lam Chan , Terry Cheuk-Fung Yip , Vincent Wai-Sun Wong , Anthony W.H. Chan , Cathy Ka Kiu Tong , Yee Kit Tse , Becky Wing-Yan Yuen , Hester Wing-Sum Luk , Grace Chung-Yan Lui , Henry L.Y. Chan , Tony S. K. Mok , Grace Lai-Hung Wong

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Hepatobiliary Cancer, Neuroendocrine/Carcinoid, Pancreatic Cancer, and Small Bowel Cancer

Track

Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Pancreatic Cancer,Small Bowel Cancer,Other GI Cancer

Sub Track

Symptoms, Toxicities, and Whole-Person Care

Citation

J Clin Oncol 38, 2020 (suppl 4; abstr 508)

Abstract #

508

Poster Bd #

B11

Abstract Disclosures

Similar Posters